Cargando…

Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers

Neoadjuvant therapy (NAT) has been used increasingly in patients with locally advanced or early-stage breast cancer. However, the accurate evaluation and prediction of response to NAT remain the great challenge. Biomarkers could prove useful to identify responders or nonresponders, or even to distin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Wenyong, Yang, Ming, Yang, Hongli, Zhou, Fangbin, Shen, Weixi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188192/ https://www.ncbi.nlm.nih.gov/pubmed/30349367 http://dx.doi.org/10.2147/CMAR.S174435

Ejemplares similares

Optimized multiparametric flow cytometric analysis of circulating endothelial cells and their subpopulations in peripheral blood of patients with solid tumors: a technical analysis
por: Zhou, Fangbin, et al.
Publicado: (2018)

Efficacy Evaluation of Neoadjuvant Chemotherapy in Breast Cancer by MRI
por: Liu, Yongguang, et al.
Publicado: (2022)

Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer
por: López-Vega, José Manuel, et al.
Publicado: (2021)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
por: Hyder, Tara, et al.
Publicado: (2021)

Neoadjuvant immunotherapy in early-stage triple negative breast cancer
por: Laouris, Panayiotis, et al.
Publicado: (2023)

Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab
por: Gollamudi, Jahnavi, et al.
Publicado: (2016)

Effect of Neoadjuvant Chemotherapy on the Serum Levels of Bone Turnover Markers in Women with Early-Stage Breast Cancer
por: Chen, YangYang, et al.
Publicado: (2015)

Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
por: Lin, Po-Han, et al.
Publicado: (2021)

Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic
por: Park, Ko Un, et al.
Publicado: (2021)

Neoadjuvant approach in patients with early breast cancer: patient assessment, staging, and planning()
por: Rubio, Isabel T., et al.
Publicado: (2021)

Diagnostics and Therapeutics in Early Stage Breast Cancer Receiving Neoadjuvant Systemic Therapy
por: Belli, Paolo, et al.
Publicado: (2023)

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy
por: Manton, D J, et al.
Publicado: (2006)

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy
por: Manton, D J, et al.
Publicado: (2006)

Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer
por: Li, Fengling, et al.
Publicado: (2021)

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival
por: Poleszczuk, Jan, et al.
Publicado: (2017)

The Dual Blockade in the Neoadjuvant Setting of HER-2 Positive Early-Stage Breast Cancer
por: Pop, Lucian, et al.
Publicado: (2019)

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
por: Leichsenring, Jonas, et al.
Publicado: (2022)

Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Li, Shunying, et al.
Publicado: (2020)

Multiparametric Contrast-Enhanced Ultrasound in Early Prediction of Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival in Breast Cancer
por: Wan, Caifeng, et al.
Publicado: (2023)

Machine learning with multiparametric magnetic resonance imaging of the breast for early prediction of response to neoadjuvant chemotherapy
por: Lo Gullo, Roberto, et al.
Publicado: (2019)

Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments
por: Qiu, Jie, et al.
Publicado: (2023)

Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Corbeau, Ileana, et al.
Publicado: (2020)

The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Cui, Jian, et al.
Publicado: (2017)

Preliminary comparison of the registration effect of 4D-CBCT and 3D-CBCT in image-guided radiotherapy of Stage IA non–small-cell lung cancer
por: Tan, Zhibo, et al.
Publicado: (2017)

Neoadjuvant Dovitinib in Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Treatment Strategies for Residual Disease following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2022)

Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients
por: Freeman, Jincong Q., et al.
Publicado: (2023)

Salivary Glycopatterns as Potential Biomarkers for Screening of Early-Stage Breast Cancer
por: Liu, Xiawei, et al.
Publicado: (2018)

Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer
por: Ni, Chao, et al.
Publicado: (2020)

Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Cui, Jian, et al.
Publicado: (2019)

Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer
por: Dayde, Delphine, et al.
Publicado: (2021)

Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer with neoadjuvant chemoradiotherapy
por: Zhao, Jie-Yi, et al.
Publicado: (2022)

Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Shi, Xinyu, et al.
Publicado: (2022)

Effect of neoadjuvant therapy on breast cancer biomarker profile
por: Rey-Vargas, Laura, et al.
Publicado: (2020)

Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients
por: Skarping, Ida, et al.
Publicado: (2020)

The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy
por: Nuvoli, Susanna, et al.
Publicado: (2018)

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Yaqi, et al.
Publicado: (2019)

Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple‐negative breast cancer
por: Zhu, Yanhui, et al.
Publicado: (2022)

Changes in the tumor oxygenation but not in the tumor volume and tumor vascularization reflect early response of breast cancer to neoadjuvant chemotherapy
por: Pavlov, Mikhail V., et al.
Publicado: (2023)

Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents
por: Garufi, Giovanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1dn1cfkn05camkci5i93c00cks